First Time Loading...

Taro Pharmaceutical Industries Ltd
NYSE:TARO

Watchlist Manager
Taro Pharmaceutical Industries Ltd Logo
Taro Pharmaceutical Industries Ltd
NYSE:TARO
Watchlist
Price: 42.85 USD -0.02% Market Closed
Updated: Jun 7, 2024

Taro Pharmaceutical Industries Ltd
Accounts Payable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Taro Pharmaceutical Industries Ltd
Accounts Payable Peer Comparison

Comparables:
TEVA
I
INCR
MDWD
R
REKA
C
CSURE

Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors

Company Accounts Payable CAGR 3Y CAGR 5Y CAGR 10Y
Taro Pharmaceutical Industries Ltd
NYSE:TARO
Accounts Payable
$44.7m
CAGR 3-Years
-10%
CAGR 5-Years
5%
CAGR 10-Years
8%
Teva Pharmaceutical Industries Ltd
TASE:TEVA
Accounts Payable
$2.4B
CAGR 3-Years
13%
CAGR 5-Years
7%
CAGR 10-Years
-3%
I
InterCure Ltd
TASE:INCR
Accounts Payable
₪133.6m
CAGR 3-Years
93%
CAGR 5-Years
107%
CAGR 10-Years
51%
Mediwound Ltd
NASDAQ:MDWD
Accounts Payable
$5.5m
CAGR 3-Years
23%
CAGR 5-Years
15%
CAGR 10-Years
17%
R
Rekah Pharmaceutical Industry Ltd
TASE:REKA
Accounts Payable
₪105.3m
CAGR 3-Years
18%
CAGR 5-Years
13%
CAGR 10-Years
3%
C
Cannassure Therapeutics Ltd
TASE:CSURE
Accounts Payable
₪6.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Taro Pharmaceutical Industries Ltd's Accounts Payable?
Accounts Payable
44.7m USD

Based on the financial report for Mar 31, 2024, Taro Pharmaceutical Industries Ltd's Accounts Payable amounts to 44.7m USD.

What is Taro Pharmaceutical Industries Ltd's Accounts Payable growth rate?
Accounts Payable CAGR 10Y
8%

Over the last year, the Accounts Payable growth was -51%. The average annual Accounts Payable growth rates for Taro Pharmaceutical Industries Ltd have been -10% over the past three years , 5% over the past five years , and 8% over the past ten years .